Transcatheter Thrombus Removal With the Penumbra Indigo Lightning System in Children With Congenital Heart Disease

Thromboembolic complications in children with congenital heart disease (CHD) carry significant morbidity and mortality, particularly in patients with single ventricle physiology. Current management strategies, including systemic anticoagulation, thrombolytics, and surgical thrombectomy, each carry substantial risks in this population. Transcatheter aspiration thrombectomy represents an emerging alternative. We retrospectively reviewed all pediatric patients with CHD at our institution who underwent transcatheter aspiration thrombectomy using the Penumbra Indigo Lightning System between January 2024 and February 2025. Patient demographics, cardiac diagnosis, thrombus location, procedural details, and clinical outcomes were recorded. Five patients (age 5 months to 9 years; weight 6.3-25.9 kg) with diverse CHD diagnoses underwent six thrombectomy procedures. Thrombus locations included the Fontan circuit, inferior vena cava, pulmonary arteries, and internal jugular veins. Technical success with angiographic restoration of antegrade flow and no residual gradient across the segment of interest, was achieved in all cases (100%). Blood loss ranged from 6 to 23 mL/kg; all patients required packed red blood cell transfusion. No significant intraprocedural hemodynamic instability occurred. Three patients were discharged home with confirmed vessel patency on follow-up imaging (echocardiography and/or vascular ultrasound at 4-6 months post intervention). Two patients, both on extracorporeal membrane oxygenation (ECMO) support prior to the procedure, subsequently died from causes unrelated to the thrombectomy intervention. In this limited case series, the Penumbra Indigo Lightning System demonstrated feasibility for transcatheter thrombus removal in pediatric patients across a spectrum of CHD. Given the limited number of available catheter systems in this population, this approach may be considered as a first-line or adjunct therapy in select patients when conventional medical management is insufficient or contraindicated. Further prospective studies are needed to define optimal patient selection, procedural techniques, and post-procedural management.

Authors

Institutions

Publication Details

Journal
Catheterization and Cardiovascular Interventions
Published
2026-11-18
DOI
https://doi.org/10.1002/ccd.71014
Primary Topic
Congenital Heart Disease Studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Transcatheter Thrombus Removal With the Penumbra Indigo Lightning System in Children With Congenital Heart Disease

Gregory A. Fleming, Kevin D. Hill, Reid C. Chamberlain, Annirudh N. Balachandran
Catheterization and Cardiovascular Interventions
Congenital Heart Disease Studies
article

Transcatheter Thrombus Removal With the Penumbra Indigo Lightning System in Children With Congenital Heart Disease

Gregory A. Fleming, Kevin D. Hill, Reid C. Chamberlain, Annirudh N. Balachandran
article en

Abstract

Thromboembolic complications in children with congenital heart disease (CHD) carry significant morbidity and mortality, particularly in patients with single ventricle physiology. Current management strategies, including systemic anticoagulation, thrombolytics, and surgical thrombectomy, each carry substantial risks in this population. Transcatheter aspiration thrombectomy represents an emerging alternative. We retrospectively reviewed all pediatric patients with CHD at our institution who underwent transcatheter aspiration thrombectomy using the Penumbra Indigo Lightning System between January 2024 and February 2025. Patient demographics, cardiac diagnosis, thrombus location, procedural details, and clinical outcomes were recorded. Five patients (age 5 months to 9 years; weight 6.3-25.9 kg) with diverse CHD diagnoses underwent six thrombectomy procedures. Thrombus locations included the Fontan circuit, inferior vena cava, pulmonary arteries, and internal jugular veins. Technical success with angiographic restoration of antegrade flow and no residual gradient across the segment of interest, was achieved in all cases (100%). Blood loss ranged from 6 to 23 mL/kg; all patients required packed red blood cell transfusion. No significant intraprocedural hemodynamic instability occurred. Three patients were discharged home with confirmed vessel patency on follow-up imaging (echocardiography and/or vascular ultrasound at 4-6 months post intervention). Two patients, both on extracorporeal membrane oxygenation (ECMO) support prior to the procedure, subsequently died from causes unrelated to the thrombectomy intervention. In this limited case series, the Penumbra Indigo Lightning System demonstrated feasibility for transcatheter thrombus removal in pediatric patients across a spectrum of CHD. Given the limited number of available catheter systems in this population, this approach may be considered as a first-line or adjunct therapy in select patients when conventional medical management is insufficient or contraindicated. Further prospective studies are needed to define optimal patient selection, procedural techniques, and post-procedural management.

Catheterization and Cardiovascular Interventions
Duke University (US), Duke Medical Center (US)
Congenital Heart Disease Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon